Correlation of serological and molecular markers in the screening for hepatitis B virus in blood bank in northern Brazil

被引:1
作者
Cruz, Lucas Jose do Nascimento [1 ,3 ]
Barile, Katarine Antonia dos santos [2 ]
Amaral, Carlos Eduardo de Melo [2 ]
机构
[1] Fundacao Prosangue Hemocentro Sao Paulo, Proc Sangue, Av Dr Eneas Carvalho de Aguiar 155, Sao Paulo, SP, Brazil
[2] Fundacao Ctr Hemoterapia & Hematol Para HEMOPA, Gerencia Biol Celular & Mol, Belem, PA, Brazil
[3] Univ Estado UEPA, Multiprofess Residency Hlth Coordinat COREMU, Travessa Perebebui 2623, BR-66087662 Belem, PA, Brazil
关键词
Hepatitis B virus; Serology; Nucleic acidamplification techniques; Viremia; Blood donors; SURFACE-ANTIGEN; HBV INFECTION; DONORS;
D O I
10.1016/j.htct.2022.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: In Brazil, the blood donor screening for hepatitis B virus (HBV) includes laboratory testing for serological (HBsAg and Anti-HBc) and molecular (HBV DNA) markers. This study aims to correlate serology reactive results with HBV DNA detection among blood donors with at least one HBV infection marker detected in a blood bank in northern Brazil.Method: A retrospective search for HBV reactive blood donor data from January 2017 to December 2019 was performed. Serological screening was performed by chemiluminescent microparticle immunoassays Architect HBsAg and Architect Anti-HBc, whereas molecular screening was performed by the HBV nucleic acid test (HBV NAT).Main results: A total of 556 HBsAg reactive results were detected, between positive (47.66%) and inconclusive (52.34%). A total of 3,658 Anti-HBc reactive results were detected, between positive (83.71%) and inconclusive (16.29%). None of the inconclusive results were associated with HBV DNA detection. The HBV DNA detection rates were 47.55% among HBsAg positive samples and 4.08% among Anti-HBc positive samples. The signal-to-cutoff (S/CO) ratio median of HBV NAT positive samples was superior in comparison to HBV NAT negative samples (p < 0.0001). The thresholds found to optimize sensitivity and specificity were 404.15 for Architect HBsAg and 7.77 for Architect Anti-HBc. Three blood donors were in the window period and 1 occult HBV infection case was detected.Conclusion: High S/CO ratios were more predictive of HBV DNA detection. However, a number of HBV NAT positive samples gave low values, while some HBV NAT negative samples showed high values, reaffirming the significance of molecular testing to enhance transfusion safety.(c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:428 / 434
页数:7
相关论文
共 30 条
[1]  
Agencia Nacional de Vigilancia Sanitaria, Diario Oficial da Uniao 2020
[2]   Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers [J].
Alzahrani, Faisal Mousa ;
Muzaheed ;
Shaikh, Saeed Sattar ;
Alomar, Amer Ibrahim ;
Acharya, Sadananda ;
Elhadi, Nasreldin .
ANNALS OF LABORATORY MEDICINE, 2019, 39 (01) :81-85
[3]   Utility of grey zone testing strategy in transfusion transmissible infection testing in blood bank is of limited value! [J].
Bhardwaj, Gunjan ;
Tiwari, Aseem K. ;
Arora, Dinesh ;
Aggarwal, Geet ;
Pabbi, Swati ;
Setya, Divya .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2020, 63 (02) :255-257
[4]  
Bhatnagar N, 2020, Indian Practitioner, V73, P35
[5]  
Bitencourt HT, 2017, Dissertation
[6]  
Calegaro MAS, 2020, Clin Biomed Res, V40, P84, DOI [10.22491/2357-9730.103797, DOI 10.22491/2357-9730.103797]
[7]   Hepatitis B virus Blood Screening: Need for Reappraisal of Blood Safety Measures? [J].
Candotti, Daniel ;
Laperche, Syria .
FRONTIERS IN MEDICINE, 2018, 5
[8]  
Chipare I, 2018, ISBT Science Series, V13, P112, DOI [10.1111/voxs.12396, 10.1111/voxs.12396, DOI 10.1111/VOXS.12396]
[9]   Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil [J].
de Miranda Correa, Angelita Silva ;
Lamarao, Leticia Martins ;
Moura Vieira, Priscilla Cristina ;
Hermes de Castro, Renata Bezerra ;
Costa de Almeida, Nubia Caroline ;
Americo de Castro, Jairo Augusto ;
Maciel de Lima, Maria Salete ;
Palmeira, Mauricio Koury ;
Langanke Pedroso Meireles, Ana Luiza ;
Burbano, Rommel Rodriguez .
PLOS ONE, 2018, 13 (12)
[10]   Anti-HBcand hepatitis B virusDNAamongHBsAg-negative blood donors from the main central blood bank units in Eastern Libya [J].
El-Nabi, Sobhy Hassab ;
El-Garawani, Islam ;
Ismail, Faisal ;
Abdelsameea, Eman .
TRANSFUSION MEDICINE, 2020, 30 (05) :401-405